BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8697451)

  • 1. Tirapazamine (SR 4233) interrupts cell cycle progression and induces apoptosis.
    Lin PS; Ho KC; Yang SJ
    Cancer Lett; 1996 Aug; 105(2):249-55. PubMed ID: 8697451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. I. Tirapazamine.
    Olive PL
    Br J Cancer; 1995 Mar; 71(3):529-36. PubMed ID: 7880735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the comet assay to identify cells sensitive to tirapazamine in multicell spheroids and tumors in mice.
    Olive PL; Vikse CM; Banath JP
    Cancer Res; 1996 Oct; 56(19):4460-3. PubMed ID: 8813141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against SR 4233 (Tirapazamine) aerobic cytotoxicity by the metal chelators desferrioxamine and tiron.
    Herscher LL; Krishna MC; Cook JA; Coleman CN; Biaglow JE; Tuttle SW; Gonzalez FJ; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):879-85. PubMed ID: 7960991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of micronucleus induction in SCCVII cells treated with bioreductive agents, WIN 59075 (SR 4233) and mitomycin C, under aerobic and hypoxic conditions.
    Shibata T; Shibamoto Y; Sasai K; Oya N; Takagi T; Murata R; Abe M
    Mutat Res; 1995 Apr; 342(3-4):171-7. PubMed ID: 7715618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms involved in the potentiation of melphalan by the bioreductive compound THNLA-1 in vitro.
    Papadopoulou MV; Ji M; Khan SH; Bloomer WD
    Oncol Res; 1999; 11(8):345-57. PubMed ID: 10803738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LET dependency of heavy-ion induced apoptosis in V79 cells.
    Aoki M; Furusawa Y; Yamada T
    J Radiat Res; 2000 Jun; 41(2):163-75. PubMed ID: 11037583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of radiation and tirapazamine (SR-4233) on three melanoma cell lines.
    Zhang M; Stevens G
    Melanoma Res; 1998 Dec; 8(6):510-5. PubMed ID: 9918413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the comet assay to detect hypoxic cells in murine tumours and normal tissues exposed to bioreductive drugs.
    Olive PL
    Acta Oncol; 1995; 34(3):301-5. PubMed ID: 7779413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of a well-behaved cell cycle in araC-treated V79 cells by caffeine.
    Das SK
    Mutat Res; 1988; 207(3-4):171-7. PubMed ID: 3357493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells.
    Zeman EM; Brown JM; Lemmon MJ; Hirst VK; Lee WW
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1239-42. PubMed ID: 3744945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The differential hypoxic cytotoxicity of bioreductive agents determined in vitro by the MTT assay.
    Stratford IJ; Stephens MA
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):973-6. PubMed ID: 2495261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tirapazamine-induced DNA damage measured using the comet assay correlates with cytotoxicity towards hypoxic tumour cells in vitro.
    Siim BG; van Zijl PL; Brown JM
    Br J Cancer; 1996 Apr; 73(8):952-60. PubMed ID: 8611431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does tirapazamine (SR-4233) have any cytotoxic or sensitizing effect on three human tumour cell lines at clinically relevant partial oxygen pressure?
    Lartigau E; Guichard M
    Int J Radiat Biol; 1995 Feb; 67(2):211-6. PubMed ID: 7884290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of low pH and hypoxia on the cytotoxic effects of SR4233 and mitomycin C in vitro.
    Skarsgard LD; Vinczan A; Skwarchuk MW; Chaplin DJ
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):363-7. PubMed ID: 8195034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bioreductive agents, tirapazamine and mitomycin C, on quiescent cell populations in solid tumors, evaluated by micronucleus assay.
    Masunaga S; Ono K; Hori H; Shibata T; Suzuki M; Kinashi Y; Takagaki M; Akaboshi M
    Jpn J Cancer Res; 1997 Sep; 88(9):907-14. PubMed ID: 9369940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual action of tirapazamine in the induction of DNA strand breaks.
    Jones GD; Weinfeld M
    Cancer Res; 1996 Apr; 56(7):1584-90. PubMed ID: 8603406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis by demecolcine in V79 cells.
    Fujikawa-Yamamoto K; Teraoka K; Zong ZP; Yamagishi H; Odashima S
    Cell Struct Funct; 1994 Dec; 19(6):391-6. PubMed ID: 7720099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre- and post-irradiation radiosensitization by SR 4233.
    Zeman EM; Brown JM
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):967-71. PubMed ID: 2703404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-nitrosocarbofuran, but not carbofuran, induces apoptosis and cell cycle arrest in CHL cells.
    Yoon JY; Oh SH; Yoo SM; Lee SJ; Lee HS; Choi SJ; Moon CK; Lee BH
    Toxicology; 2001 Dec; 169(2):153-61. PubMed ID: 11718956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.